Japan Bold Biotechnology Co., Ltd (known as BBT) is a comprehensive health industry group with its own excellent life health technology. BBT committed to develop the world’s most advanced and leading technology including cancer prevention, treatment of immune cells (BAK, NK, DC immunotherapy), exosome research and development, stem cell culture medium for serum-free immune cells, ultra-early stage cancer detection, fermented horse milk exosomes research and manufacturing, high concentration Vitamin C production and over 10 leading biotechnologies.
At the same time, with our top biotechnologies and excellent business operation, BBTF convert the most advanced medical-use biotechnologies development to end-user product at the fastest speed. BBTF act as a pioneer in the field by developing life health technology with most advanced biotechnology.